1. Home
  2. ECO vs TRVI Comparison

ECO vs TRVI Comparison

Compare ECO & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Okeanis Eco Tankers Corp.

ECO

Okeanis Eco Tankers Corp.

HOLD

Current Price

$52.10

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$16.96

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ECO
TRVI
Founded
2018
2011
Country
Greece
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
ECO
TRVI
Price
$52.10
$16.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$42.00
$21.55
AVG Volume (30 Days)
395.2K
1.1M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
6.12%
N/A
EPS Growth
N/A
31.91
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.07
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.27
$5.41
52 Week High
$58.45
$16.80

Technical Indicators

Market Signals
Indicator
ECO
TRVI
Relative Strength Index (RSI) 53.00 72.54
Support Level $47.91 $10.07
Resistance Level $52.96 N/A
Average True Range (ATR) 1.90 0.74
MACD 0.43 0.34
Stochastic Oscillator 75.21 96.83

Price Performance

Historical Comparison
ECO
TRVI

About ECO Okeanis Eco Tankers Corp.

Okeanis Eco Tankers Corp is an international owner and operator of a fleet of tanker vessels used for the transportation of crude oil. Its fleet consists of modern Suezmax and VLCC tankers that are designed in accordance with eco-efficiency standards, including features such as reduced fuel consumption, exhaust gas cleaning systems, and ballast water treatment systems. All of the company's revenue is derived from a single segment, the crude oil tanker segment. Geographically, the maximum revenue is generated from Europe, and the rest from Asia, North America, and South America.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Share on Social Networks: